S&P 500   3,179.83 (-1.43%)
DOW   27,587.90 (-1.33%)
QQQ   218.22 (-1.43%)
AAPL   291.15 (-2.36%)
FB   199.59 (-0.56%)
MSFT   170.43 (-0.27%)
GOOGL   1,413.23 (-0.47%)
AMZN   1,978.03 (-1.56%)
CGC   19.70 (-2.96%)
NVDA   259.68 (-4.98%)
BABA   205.46 (-0.34%)
MU   52.85 (-3.93%)
GE   11.46 (-3.37%)
TSLA   791.03 (-5.13%)
AMD   47.66 (-2.97%)
T   38.06 (+0.03%)
ACB   1.50 (-3.23%)
F   7.43 (-1.85%)
NFLX   359.62 (-2.46%)
S&P 500   3,179.83 (-1.43%)
DOW   27,587.90 (-1.33%)
QQQ   218.22 (-1.43%)
AAPL   291.15 (-2.36%)
FB   199.59 (-0.56%)
MSFT   170.43 (-0.27%)
GOOGL   1,413.23 (-0.47%)
AMZN   1,978.03 (-1.56%)
CGC   19.70 (-2.96%)
NVDA   259.68 (-4.98%)
BABA   205.46 (-0.34%)
MU   52.85 (-3.93%)
GE   11.46 (-3.37%)
TSLA   791.03 (-5.13%)
AMD   47.66 (-2.97%)
T   38.06 (+0.03%)
ACB   1.50 (-3.23%)
F   7.43 (-1.85%)
NFLX   359.62 (-2.46%)
S&P 500   3,179.83 (-1.43%)
DOW   27,587.90 (-1.33%)
QQQ   218.22 (-1.43%)
AAPL   291.15 (-2.36%)
FB   199.59 (-0.56%)
MSFT   170.43 (-0.27%)
GOOGL   1,413.23 (-0.47%)
AMZN   1,978.03 (-1.56%)
CGC   19.70 (-2.96%)
NVDA   259.68 (-4.98%)
BABA   205.46 (-0.34%)
MU   52.85 (-3.93%)
GE   11.46 (-3.37%)
TSLA   791.03 (-5.13%)
AMD   47.66 (-2.97%)
T   38.06 (+0.03%)
ACB   1.50 (-3.23%)
F   7.43 (-1.85%)
NFLX   359.62 (-2.46%)
S&P 500   3,179.83 (-1.43%)
DOW   27,587.90 (-1.33%)
QQQ   218.22 (-1.43%)
AAPL   291.15 (-2.36%)
FB   199.59 (-0.56%)
MSFT   170.43 (-0.27%)
GOOGL   1,413.23 (-0.47%)
AMZN   1,978.03 (-1.56%)
CGC   19.70 (-2.96%)
NVDA   259.68 (-4.98%)
BABA   205.46 (-0.34%)
MU   52.85 (-3.93%)
GE   11.46 (-3.37%)
TSLA   791.03 (-5.13%)
AMD   47.66 (-2.97%)
T   38.06 (+0.03%)
ACB   1.50 (-3.23%)
F   7.43 (-1.85%)
NFLX   359.62 (-2.46%)
Log in

Anavex Life Sciences News Headlines (NASDAQ:AVXL)

$4.37
-0.35 (-7.42 %)
(As of 02/25/2020 11:24 AM ET)
Today's Range
$4.29
Now: $4.37
$4.78
50-Day Range
$2.85
MA: $3.71
$5.81
52-Week Range
$2.10
Now: $4.37
$6.31
Volume869,317 shs
Average Volume1.30 million shs
Market Capitalization$256.37 million
P/E RatioN/A
Dividend YieldN/A
Beta2.11

Headlines

Anavex Life Sciences (NASDAQ AVXL) News Headlines

Source:
DateHeadline
Anavex Life Sciences Announces Publication of Foundational Data for ANAVEX(R)2-73 (blarcamesine) in Multiple Sclerosis (MS)Anavex Life Sciences Announces Publication of Foundational Data for ANAVEX(R)2-73 (blarcamesine) in Multiple Sclerosis (MS)
www.marketwatch.com - February 24 at 5:34 PM
Anavex Life Sciences gains after posting dataAnavex Life Sciences gains after posting data
seekingalpha.com - February 24 at 5:34 PM
Anavex Life Sciences Announces Publication of Foundational Data for ANAVEX®2-73 (blarcamesine) in Multiple Sclerosis (MS)Anavex Life Sciences Announces Publication of Foundational Data for ANAVEX®2-73 (blarcamesine) in Multiple Sclerosis (MS)
finance.yahoo.com - February 24 at 7:33 AM
-$0.14 Earnings Per Share Expected for Anavex Life Sciences Corp (NASDAQ:AVXL) This Quarter-$0.14 Earnings Per Share Expected for Anavex Life Sciences Corp (NASDAQ:AVXL) This Quarter
www.americanbankingnews.com - February 22 at 11:26 PM
All You Need to Know About Anavex Life Sciences (AVXL) Rating Upgrade to Strong BuyAll You Need to Know About Anavex Life Sciences (AVXL) Rating Upgrade to Strong Buy
finance.yahoo.com - February 17 at 2:43 PM
Anavex Life Sciences Corp (NASDAQ:AVXL) Receives Average Rating of "Buy" from AnalystsAnavex Life Sciences Corp (NASDAQ:AVXL) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - February 14 at 4:53 PM
Ultragenyx (RARE) Reports Wider-Than-Expected Loss in Q4Ultragenyx (RARE) Reports Wider-Than-Expected Loss in Q4
finance.yahoo.com - February 14 at 12:32 PM
4 Momentum Stocks To Watch4 Momentum Stocks To Watch
finance.yahoo.com - February 13 at 5:29 PM
Anavex Life Sciences (AVXL) Investor Presentation - SlideshowAnavex Life Sciences (AVXL) Investor Presentation - Slideshow
seekingalpha.com - February 11 at 5:46 PM
Edited Transcript of AVXL earnings conference call or presentation 6-Feb-20 9:30pm GMTEdited Transcript of AVXL earnings conference call or presentation 6-Feb-20 9:30pm GMT
finance.yahoo.com - February 9 at 5:34 PM
Anavex Life Sciences (NASDAQ:AVXL) Posts  Earnings Results, Beats Expectations By $0.02 EPSAnavex Life Sciences (NASDAQ:AVXL) Posts Earnings Results, Beats Expectations By $0.02 EPS
www.americanbankingnews.com - February 7 at 7:03 PM
Anavex Life Sciences (AVXL) CEO Christopher Missling on Q1 2020 Results - Earnings Call TranscriptAnavex Life Sciences' (AVXL) CEO Christopher Missling on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - February 6 at 8:18 PM
Anavex Life Sciences Corp. to Host Earnings CallAnavex Life Sciences Corp. to Host Earnings Call
finance.yahoo.com - February 6 at 3:17 PM
Anavex Life Sciences Reports Fiscal 2020 First Quarter Financial Results and Provides Clinical Study UpdatesAnavex Life Sciences Reports Fiscal 2020 First Quarter Financial Results and Provides Clinical Study Updates
finance.yahoo.com - February 6 at 10:17 AM
Anavex Life Sciences to Present and Participate in a Panel at the 2020 BIO CEO & Investor ConferenceAnavex Life Sciences to Present and Participate in a Panel at the 2020 BIO CEO & Investor Conference
finance.yahoo.com - February 4 at 11:18 AM
Stock To Watch: Anavex Life SciencesStock To Watch: Anavex Life Sciences
www.nasdaq.com - February 4 at 6:17 AM
Mid-Afternoon Market Update: NASDAQ Rises Over 1%; Anavex Life Sciences Shares SurgeMid-Afternoon Market Update: NASDAQ Rises Over 1%; Anavex Life Sciences Shares Surge
www.benzinga.com - February 3 at 5:27 PM
Anavex Life Sciences Announces Fast Track Designation Granted by U.S. FDA for ANAVEX®2-73 (blarcamesine) Clinical Development Program for the Treatment of Rett SyndromeAnavex Life Sciences Announces Fast Track Designation Granted by U.S. FDA for ANAVEX®2-73 (blarcamesine) Clinical Development Program for the Treatment of Rett Syndrome
finance.yahoo.com - February 3 at 7:27 AM
Is Anavex Life Sciences (AVXL) Stock Outpacing Its Medical Peers This Year?Is Anavex Life Sciences (AVXL) Stock Outpacing Its Medical Peers This Year?
finance.yahoo.com - January 31 at 5:59 PM
Anavex Life Sciences Corp (NASDAQ:AVXL) Expected to Post Earnings of -$0.12 Per ShareAnavex Life Sciences Corp (NASDAQ:AVXL) Expected to Post Earnings of -$0.12 Per Share
www.americanbankingnews.com - January 31 at 9:37 AM
Anavex Life Sciences (AVXL) Set to Announce Quarterly Earnings on ThursdayAnavex Life Sciences (AVXL) Set to Announce Quarterly Earnings on Thursday
www.americanbankingnews.com - January 31 at 9:21 AM
Anavex Life Sciences to Announce Fiscal 2020 First Quarter Financial Results on Thursday, February 6th, 2020Anavex Life Sciences to Announce Fiscal 2020 First Quarter Financial Results on Thursday, February 6th, 2020
finance.yahoo.com - January 30 at 9:08 AM
Anavex Life completes enrollment in mid-stage blarcamesine study; shares up 5% premarketAnavex Life completes enrollment in mid-stage blarcamesine study; shares up 5% premarket
seekingalpha.com - January 27 at 9:23 AM
Anavex Life Sciences Announces Achievement of Enrollment Target for the ANAVEX®2-73 (blarcamesine) Phase 2 Parkinson’s Disease Dementia (PDD) Clinical TrialAnavex Life Sciences Announces Achievement of Enrollment Target for the ANAVEX®2-73 (blarcamesine) Phase 2 Parkinson’s Disease Dementia (PDD) Clinical Trial
finance.yahoo.com - January 27 at 9:23 AM
Implied Volatility Surging for Anavex (AVXL) Stock OptionsImplied Volatility Surging for Anavex (AVXL) Stock Options
finance.yahoo.com - January 23 at 4:25 PM
Anavex Life Sciences (AVXL) Moves to Strong Buy: Rationale Behind the UpgradeAnavex Life Sciences (AVXL) Moves to Strong Buy: Rationale Behind the Upgrade
finance.yahoo.com - January 14 at 5:32 PM
Anavex Life Sciences nabs new patent in U.S.; shares up 7% premarketAnavex Life Sciences nabs new patent in U.S.; shares up 7% premarket
seekingalpha.com - January 8 at 3:56 PM
Amarin Posts '19 Preliminary Results, Gives 2020 Expense ViewAmarin Posts '19 Preliminary Results, Gives 2020 Expense View
finance.yahoo.com - January 8 at 3:56 PM
Anavex Life Sciences Issued New U.S. Patent for ANAVEX®2-73 Treatment of Neurodevelopmental Disorders including Rett Syndrome and Multiple SclerosisAnavex Life Sciences Issued New U.S. Patent for ANAVEX®2-73 Treatment of Neurodevelopmental Disorders including Rett Syndrome and Multiple Sclerosis
finance.yahoo.com - January 8 at 7:22 AM
Will Anavex Life Continue to Surge Higher?Will Anavex Life Continue to Surge Higher?
finance.yahoo.com - December 27 at 8:38 AM
Hedge Funds Aren’t Crazy About Anavex Life Sciences Corp. (AVXL) AnymoreHedge Funds Aren’t Crazy About Anavex Life Sciences Corp. (AVXL) Anymore
finance.yahoo.com - December 24 at 4:27 AM
Edited Transcript of AVXL earnings conference call or presentation 16-Dec-19 9:30pm GMTEdited Transcript of AVXL earnings conference call or presentation 16-Dec-19 9:30pm GMT
finance.yahoo.com - December 17 at 10:09 PM
Anavex Life Sciences EPS beats by $0.08Anavex Life Sciences EPS beats by $0.08
seekingalpha.com - December 16 at 10:58 AM
Anavex Life Sciences Reports Fiscal Year 2019 Financial Results And Provides Clinical Study UpdatesAnavex Life Sciences Reports Fiscal Year 2019 Financial Results And Provides Clinical Study Updates
www.marketwatch.com - December 16 at 10:58 AM
Anavex Life Sciences Reports Fiscal Year 2019 Financial Results And Provides Clinical Study UpdatesAnavex Life Sciences Reports Fiscal Year 2019 Financial Results And Provides Clinical Study Updates
finance.yahoo.com - December 16 at 10:58 AM
Anavex Life Sciences to Announce Fiscal 2019 Year End Financial Results on Monday December 16, 2019Anavex Life Sciences to Announce Fiscal 2019 Year End Financial Results on Monday December 16, 2019
finance.yahoo.com - December 10 at 8:04 AM
Anavex Life Sciences Presents ANAVEX(R)2-73 (blarcamesine) Data at 12th Clinical Trials on Alzheimers Disease (CTAD) 2019 ConferenceAnavex Life Sciences Presents ANAVEX(R)2-73 (blarcamesine) Data at 12th Clinical Trials on Alzheimer's Disease (CTAD) 2019 Conference
www.marketwatch.com - December 4 at 12:16 PM
Anavex shares rise in advance of Alzheimer's meetingAnavex shares rise in advance of Alzheimer's meeting
finance.yahoo.com - December 4 at 12:16 PM
Anavex Life Sciences Presents ANAVEX®2-73 (blarcamesine) Data at 12th Clinical Trials on Alzheimers Disease (CTAD) 2019 ConferenceAnavex Life Sciences Presents ANAVEX®2-73 (blarcamesine) Data at 12th Clinical Trials on Alzheimer's Disease (CTAD) 2019 Conference
finance.yahoo.com - December 4 at 7:15 AM
Anavex Life Sciences Receives Rare Pediatric Disease Designation from FDA for ANAVEX(R)2-73 (blarcamesine) for the Treatment of Rett SyndromeAnavex Life Sciences Receives Rare Pediatric Disease Designation from FDA for ANAVEX(R)2-73 (blarcamesine) for the Treatment of Rett Syndrome
www.marketwatch.com - November 14 at 9:33 AM
Anavex Life Sciences Receives Rare Pediatric Disease Designation from FDA for ANAVEX®2-73 (blarcamesine) for the Treatment of Rett SyndromeAnavex Life Sciences Receives Rare Pediatric Disease Designation from FDA for ANAVEX®2-73 (blarcamesine) for the Treatment of Rett Syndrome
finance.yahoo.com - November 14 at 9:33 AM
Anavex Life Sciences Announces Publication of Foundational Data for ANAVEX(R)2-73 (blarcamesine) in Rett SyndromeAnavex Life Sciences Announces Publication of Foundational Data for ANAVEX(R)2-73 (blarcamesine) in Rett Syndrome
www.marketwatch.com - November 6 at 10:47 AM
Anavex Life Sciences Announces Publication of Foundational Data for ANAVEX®2-73 (blarcamesine) in Rett SyndromeAnavex Life Sciences Announces Publication of Foundational Data for ANAVEX®2-73 (blarcamesine) in Rett Syndrome
finance.yahoo.com - November 6 at 10:47 AM
Anavex Life Sciences Corp.Anavex Life Sciences Corp.
www.marketwatch.com - October 23 at 3:34 PM
All You Need to Know About Anavex Life Sciences (AVXL) Rating Upgrade to BuyAll You Need to Know About Anavex Life Sciences (AVXL) Rating Upgrade to Buy
finance.yahoo.com - October 23 at 10:34 AM
Anavex Life Sciences Announces ATTENTION-AD ANAVEX(R)2-73 Extension Clinical Study in Early Alzheimers DiseaseAnavex Life Sciences Announces ATTENTION-AD ANAVEX(R)2-73 Extension Clinical Study in Early Alzheimer's Disease
www.marketwatch.com - October 9 at 8:26 AM
Anavex Life Sciences Announces ATTENTION-AD ANAVEX®2-73 Extension Clinical Study in Early Alzheimer’s DiseaseAnavex Life Sciences Announces ATTENTION-AD ANAVEX®2-73 Extension Clinical Study in Early Alzheimer’s Disease
finance.yahoo.com - October 9 at 8:26 AM
Anavex Life Sciences Issued New U.S. Patent for Composition of Matter Covering ANAVEX(R)2-73 for the Treatment of Alzheimers DiseaseAnavex Life Sciences Issued New U.S. Patent for Composition of Matter Covering ANAVEX(R)2-73 for the Treatment of Alzheimer's Disease
www.marketwatch.com - October 2 at 2:52 PM
Anavex Life Sciences Issued New U.S. Patent for Composition of Matter Covering ANAVEX®2-73 for the Treatment of Alzheimer’s DiseaseAnavex Life Sciences Issued New U.S. Patent for Composition of Matter Covering ANAVEX®2-73 for the Treatment of Alzheimer’s Disease
finance.yahoo.com - October 2 at 2:52 PM
Anavex Life Sciences Presented at the 6th Annual European Rett Syndrome Conference Preliminary Clinical Efficacy Data from the U.S. Rett Syndrome Phase 2 ANAVEX®2-73 StudyAnavex Life Sciences Presented at the 6th Annual European Rett Syndrome Conference Preliminary Clinical Efficacy Data from the U.S. Rett Syndrome Phase 2 ANAVEX®2-73 Study
finance.yahoo.com - September 27 at 7:24 AM
This page was last updated on 2/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel